FR3678M - 2-methyl, 2-propylpropanediol-1,3 nicotinate as a novel drug for muscle pain, arterial and venous disorders and pharmaceutical compositions for its use. - Google Patents

2-methyl, 2-propylpropanediol-1,3 nicotinate as a novel drug for muscle pain, arterial and venous disorders and pharmaceutical compositions for its use.

Info

Publication number
FR3678M
FR3678M FR960530A FR960530A FR3678M FR 3678 M FR3678 M FR 3678M FR 960530 A FR960530 A FR 960530A FR 960530 A FR960530 A FR 960530A FR 3678 M FR3678 M FR 3678M
Authority
FR
France
Prior art keywords
propylpropanediol
nicotinate
arterial
methyl
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR960530A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH S PHARMA ERPHAR SOC ET
Original Assignee
RECH S PHARMA ERPHAR SOC ET
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH S PHARMA ERPHAR SOC ET filed Critical RECH S PHARMA ERPHAR SOC ET
Priority to FR960530A priority Critical patent/FR3678M/en
Application granted granted Critical
Publication of FR3678M publication Critical patent/FR3678M/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR960530A 1964-01-16 1964-01-16 2-methyl, 2-propylpropanediol-1,3 nicotinate as a novel drug for muscle pain, arterial and venous disorders and pharmaceutical compositions for its use. Expired FR3678M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR960530A FR3678M (en) 1964-01-16 1964-01-16 2-methyl, 2-propylpropanediol-1,3 nicotinate as a novel drug for muscle pain, arterial and venous disorders and pharmaceutical compositions for its use.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR960530A FR3678M (en) 1964-01-16 1964-01-16 2-methyl, 2-propylpropanediol-1,3 nicotinate as a novel drug for muscle pain, arterial and venous disorders and pharmaceutical compositions for its use.

Publications (1)

Publication Number Publication Date
FR3678M true FR3678M (en) 1965-11-15

Family

ID=8821042

Family Applications (1)

Application Number Title Priority Date Filing Date
FR960530A Expired FR3678M (en) 1964-01-16 1964-01-16 2-methyl, 2-propylpropanediol-1,3 nicotinate as a novel drug for muscle pain, arterial and venous disorders and pharmaceutical compositions for its use.

Country Status (1)

Country Link
FR (1) FR3678M (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064286A2 (en) * 1981-05-06 1982-11-10 ALFA FARMACEUTICI S.p.A. New derivatives of alkanediols having hypolipidaemic activity, methods for their preparation and pharmaceutical compositions containing them

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064286A2 (en) * 1981-05-06 1982-11-10 ALFA FARMACEUTICI S.p.A. New derivatives of alkanediols having hypolipidaemic activity, methods for their preparation and pharmaceutical compositions containing them
EP0064286A3 (en) * 1981-05-06 1983-03-02 ALFA FARMACEUTICI S.p.A. New derivatives of alkanediols having hypolipidaemic activity, methods for their preparation and pharmaceutical compositions containing them

Similar Documents

Publication Publication Date Title
FR2427M (en) Bacteriotherapeutic drug, in particular for the treatment of gastrointestinal disorders.
FR2348201A1 (en) NEW DRUGS FOR THE TREATMENT OF ISCHEMIC VASCULAR DISORDERS
FR3043M (en) Medicinal product based on a new series of 1-aryl-4-oxo-1,3,8-triazaspiro- (4,5) -decanes, substituted in position 8 or their salts for the treatment of mental disorders.
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
DK134465B (en) Eye action for controlled continuous administration of a predetermined dose of drug to the eye.
FR1215M (en) New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenia.
FR3678M (en) 2-methyl, 2-propylpropanediol-1,3 nicotinate as a novel drug for muscle pain, arterial and venous disorders and pharmaceutical compositions for its use.
FR3851M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR3672M (en) Medicinal product based on nicotinic acid derivatives for the treatment of circulatory disorders.
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3161M (en) Quercetol nicotinate as a new medicament for circulatory, peripheral, venous and arterial disorders and pharmaceutical compositions for its administration.
FR1782M (en) Cetyl nicotinate as an analgesic and repellant and pharmaceutical compositions for its administration, in particular by the percutaneous route.
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR3532M (en) New drug, in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2501M (en) Di-p.acetaminophenol succinate as an antipyretic analgesic antirheumatic drug and pharmaceutical compositions for its administration.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR2683M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR3670M (en) New oral drug for the treatment of chronic tissue ulcerations.
FR3635M (en) Pharmaceutical preparations for the treatment of cardio-circulatory disorders, based on 1,4-benzodioxane derivatives.
NL156921B (en) PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION CONTAINING AS THE ACTIVE INGREDIENT 4-METHYL-5- (2'-CHLORETHYL) -THIA SOLE AND FORMED THERAPEUTIC PREPARED UNDER THIS PROCESS.
FR2046M (en) Pentaerythritis tetranicotinate as a lipotropic and pharmaceutical compositions for its administration.
FR3633M (en) New drug to treat blood alcohol level.
FR289M (en) Medicinal product for use in the treatment of hypercholesterolemia and related conditions, based on thyronine derivatives.